chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient was given the vaccine on 5-31-15. She called on 6-2-15 and reported dizziness and nausea since the vaccine.
I63.9 - Cerebral infarction, unspecified VOMITING ABDOMINAL PAIN
vertigo; High fever; Fatigue; Chills; Aches and pains; unable to walk; This is a spontaneous report from a contactable consumer (patient).A 70-years-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection), via an unspecified route of administration, administered in Arm Right on 18Feb2021 at 1:00 PM (Batch/Lot Number: EN9581) as 2nd dose, single for covid-19 immunization.Medical history included hypertension, hypothyroidism and blood cholesterol increased. The patient had allergies to Bactrim and Levaquin. The other medications within two weeks included unspecified blood pressure, statin, thyroid medications.The patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection), via an unspecified route of administration, administered in Arm Right on 28Jan2021 at 1:00 PM (Batch/Lot Number: EL3247) as 1st dose, single for covid-19 immunization. No other vaccine in four weeks. On 19Feb2021 at 08:00 AM, the patient experienced vertigo, high fever, fatigue, chills, aches and pains, unable to walk. It was reported that the patient had high fever and fatigue within 10 hours, chills, aches and pains and 48 hours later, severe vertigo could not left my head up and unable to walk without help. This lasted 24 hours - and is still slightly apparent 24 hours later. No treatment was given for events. No COVID prior vaccination. Patient has not tested COVID post vaccination. The outcome of events was recovering.  No follow-up attempts are possible. No further information is expected.
Rash; Difficulty Breathing; Dizziness; A spontaneous report was received from a consumer concerning a 47-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events rash, difficulty breathing, dizziness.  The patient's medical history was not provided. No relevant concomitant medications were reported.  No relevant lab data was provided by the reporter.  On 23 Feb 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: Detail Batch Number) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 23 Feb 2021, the patient experienced the event(s) rash. difficulty breathing, dizziness.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), rash, difficulty breathing, dizziness was unknown.
Knot in vaccine site muscle, worsening pain over about one week, continuing decreased strength and mobility. Even in the right shoulder.
Patient called to report ongoing asthmatic symptoms that  started overnight  following administration   of vaccine, she describes being unable to breathe when laying down. She treated with Singulair with no relief.  Patient repots feeling well while standing, but could not lay down to sleep. I advised patient   to call  her PCP  immediately.  PCP recommended ED, but patient elected to wait a second night. Called patient  to follow up  7/5/21 &  she reports being fully  back to baseline  after 48hr of dyspnea.
muscle spasm/ spasms in all his old injuries; eyes were itchy; one nostril started bleeding; Hypersensitivity reaction; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (muscle spasm/ spasms in all his old injuries), EYE PRURITUS (eyes were itchy), EPISTAXIS (one nostril started bleeding) and HYPERSENSITIVITY (Hypersensitivity reaction) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048B21A) for COVID-19 vaccination.     The patient's past medical history included Sinus disorder and Fall (In the past he fell of a ladder onto his back). Concurrent medical conditions included Blood pressure high, Allergy and Cholesterol. Concomitant products included SIMVASTATIN for Blood pressure high, LISINOPRIL for an unknown indication.   On 19-Apr-2021 at 10:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Apr-2021, the patient experienced HYPERSENSITIVITY (Hypersensitivity reaction). On an unknown date, the patient experienced MUSCLE SPASMS (muscle spasm/ spasms in all his old injuries), EYE PRURITUS (eyes were itchy) and EPISTAXIS (one nostril started bleeding). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, MUSCLE SPASMS (muscle spasm/ spasms in all his old injuries), EYE PRURITUS (eyes were itchy), EPISTAXIS (one nostril started bleeding) and HYPERSENSITIVITY (Hypersensitivity reaction) had not resolved. Not Provided          Most recent FOLLOW-UP information incorporated above includes: On 06-Aug-2021: Follow up information received contains added Patient demographics, concomitant medication, new event hypersensitivity and event outcome updated.
This spontaneous report has been received from a physician via a company representative and refers to a 13-year-old female patient. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. In August 2015 and in August 2016, the patient was vaccinated with the first and second dose of GARDASIL 9 (dose, route of administration, lot # and expiration date were not reported). In August 2016, after the second dose, the patient experienced rhabdomyolysis and polyarticular arthritis and was hospitalized. The patient received treatment for the adverse events. The patient had unspecified laboratory test performed. The outcome of the events was not reported (dechallenge was also reported as "Yes, after stopping therapy"). The relatedness between the events and GARDASIL 9 was not reported. Upon internal review, the events of rhabdomyolysis and polyarticular arthritis were considered to be medically significant. Additional information has been requested.
Around bed time experienced fever, chills and body aches. Slept about 4 hours and took a Tylenol that helped me. The fever was lingering next day but was under control as long as I was taking it every 6 hours. The fever would get worse around night time.  The next night I noticed a red area at the injection site, the size of a dollar, very swollen and bruised. I just used hot compress and hydrocortisone and it kept getting bigger. On the 4th or 5th day  I reached out to the telehealth offered by her insurance company and reached out to get their opinion, The MD did a virtual visit and identified it as cellulitis. Keflex was prescribed and it went away right away. The fever had subsided the morning of my 3rd day after the vaccine. I had COVID in November, tested positive 11/12/2020.
Chest tightening; Muscle Tightening; Nausea; Cold Sweats; Loss of Appetite; fatigue; headache; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old, female patient received first dose of BNTI62b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955), via an unspecified route of administration in the left arm on 23Mar2021 at 10:45 (at the age of 47-yeasr-old) as a single dose for COVID-19 immunisation. The patient medical history was reported as high blood pressure, kidney and gallstones, depression, and bladder tumor. Concomitant medications were reported (unspecified drug). The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. On 28Mar2021 at 05:00, the patient experienced chest tightening, headache, nausea, cold sweats, muscle tightening - type headache, loss of appetite and fatigue. The patient did not receive any treatment for the reported adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care.  The clinical outcome of the events chest tightening, headache, nausea, cold sweats, muscle tightening, loss of appetite and fatigue was not recovered at the time of report.  No follow-up attempts are needed. No further information is expected.
Vaccine given at 3:20pm.  At 3:45pm she c/0 nausea.  B/P - 120/78, face mildly flushed.  Refused ambulance.  4pm c/o chest "tightness".  Then denied it.  c/0 nausea, lightheadedness, dizziness.  Mother arrived and client ambulated to car without help.  Agreed to go to ER.
Breakthrough COVID infection. Tested positive 07/13/2022. Fever and worsening fatigue starting 07/13/2022.
Diverticulitis of large intestine without perforation or abscess with bleeding - procedure- laparoscopic cholecystectomy with cholangiogram. Recovered in hospital. ED visit to hospital admission within 6 weeks of receiving the COVID vaccine. Treated again in the ED 2 days later for shortness of breath.
Headache, Fever, NauseaVomiting, injection site soreness, chill Narrative:
4 Patients received their 2 nd dose from a vial greater than 12 hours post puncture; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (4 Patients received their 2 nd dose from a vial greater than 12 hours post puncture) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 076C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Oct-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (4 Patients received their 2 nd dose from a vial greater than 12 hours post puncture). On 26-Oct-2021, EXPIRED PRODUCT ADMINISTERED (4 Patients received their 2 nd dose from a vial greater than 12 hours post puncture) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant information was reported. No treatment information was reported.
Pt complained of dizziness and warmth. Pt was visibly sweating and pale in color. Pt complained of difficulty breathing.
Drew up 0.3 mL undiluted, pfizer bivalent vaccine for 5-11 year old patients. And administered.
Diagnosis: Varicella with vaccine 11/17/1998. 05/09/04-Tired--Less Active-No temp. taken  05/10/04-Red raised rash (torso and face)  05/11/04-Rash became vesicles  05/12/04-vesicles--various stages pustules mild puritis
Dizziness/wooziness, shortness of breath, muscle aches, high BP and heart rate
Edematous swelling, erythema and warmth of left deltoid to elbow. Started 20 hrs after vaccination. No other symptoms.
Not certain if HPV or meningococcal vacc in the R deltoid. One of them was. Documentation error indicated both in L deltoid. Developed pain in right shoulder with limited active ROM within 14 hours of vaccination. Over 2 weeks, ROM improved. On exam today, symptoms consistent with impingement of the R shoulder.
Angioedema, erythema and tenderness in a large area around the right deltoid injection site.
08/29/22 presents to EC ED for "cough/aches". PMHx of "HTN and GERD" "urgent care on 8/27 where she tested positive for COVID"
Migraine headaches  Fast heart beat Muscle weakness Tinnitus   Constipation Dizzy  Breast implant ruptured
Started fussing & running high fever t103 R 3 hrs p/#3 DTP; pt sleep fitfully; pt taken to ER was lethargic, uncontrollable crying all next day; would not take food or liquid; lips blue, tongue swollen, uncoordinated, sz, eyes rolled back;
Onset of symptoms 3-4 hours after injection: gasping difficulty breathing, cyanotic lips, rash on upper back
02Feb2021=1dose and 02Feb2021=2dose; Hand Joint pain; Hand Joint pain and swelling; This is a spontaneous report from a contactable consumer. This 53-year-old male consumer reported for a himself.  A 53-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection, Batch/Lot Number: EZ9266), dose 2 via an unspecified route of administration, administered in Arm Left on an unspecified date as DOSE 2, SINGLE, dose 1 via an unspecified route of administration, administered in Arm Left on 02Feb2021 15:45 (Batch/Lot Number: EN5318) as DOSE 1, SINGLE for covid-19 immunization. Concomitant medication(s) included escitalopram oxalate (LEXAPRO), esomeprazole magnesium (NEXIUM MUPS [ESOMEPRAZOLE MAGNESIUM]) montelukast (MONTELUKAST) taken for an unspecified indication, start and stop date were not reported. On 12Jun2021 The patient underwent lab tests and procedures which included sars-cov-2 test: negative. No other vaccine in four weeks. No Covid test  prior vaccination. On an unspecified date The patient experienced 02feb2021=1dose and 02feb2021=2dose, On 20May2021 05:15 hand joint pain, hand joint pain and swelling. Events were consider as non serious. Therapeutic measures were taken as a result of hand joint pain, hand joint pain and swelling. The outcome of events hand joint pain, hand joint pain and swelling were not resolved and rest was unknown.   Follow-up attempts are completed. No further information is expected.
Pt received Tdap + Typhoid 3/9/09 for pre-travel immunization.  Within 10 min of receiving vaccine pt c/o pain + swelling L posterior deltoid.  Pt. denied SOB, facial swelling, wheezing.  V/S monitored, ice applied + pt. observed + assessed by HD.
Although I have heart disease, and had triple bypass surgery three  years ago, I consistently take my blood pressure. My blood pressure has been in a  normal range since the operation, and following receiving the first dose of the vaccine it became elevated and I needed to go back on an old medication. Even then, my blood pressure was erratic.  Two weeks after my 2nd COVID shot I had a heart attack due to a blood clot. This clot was able to be removed by a heart cath-lab.  This could be a coincidental flare up due to an old issue, but the timing aligns with both doses of the vaccine.
About an hour or two after receiving the Moderna COVID-19 booster, I got an unusual pain in my lower/mid back (near my lower ribs). It's not as bad today (second day), but I'm still noticing some discomfort in the same area. I'm also sore in the area around the injection site.
Pt asked for covid vaccine and said she had never had it, but after administered I found that she had had Moderna one dose only in February 2021.
somebody else got Shingles after their second dose; This is a spontaneous report from a contactable consumer or other non-HCP. A patient of unspecified age and gender received second doe of BNT162B2 (COMIRNATY, solution for injection; Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date as a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The reporter stated that she knew somebody else got shingles after their second dose on an unspecified date. The outcome of the event was unknown.  The lot number for the vaccine BNT162B2 was not provided and will be requested during follow up.
Pt seen in EC with complaints of redness, swelling, hot to touch, and soreness at injection site.  Pt assessed and discharged with Benadryl 25 mg and prednisone dose pack.
Fever, body aches, headache, nauseia, chills, sweats, weakness, fatigue, loss of appetite.  Began to feel weak and chill in the evening, sweat profusely all night.
Syringe malfunctioned and patient only received partial dose of vaccine. Patient was given remainder of the dose with new syringe
No adverse reaction.  Lot number expired 10/24/2022.  Called Pfizer for guidance for the need of re administration of dose and interval if needed.
Bad flue symptoms; Fever of 102.5; patient is 11 years old; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 11 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 30Jan2022 09:30 (Lot number: FL0007) at the age of 11 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Past drug history included: No, notes: No. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: FK5618, Location of injection: Arm Left, Vaccine Administration Time: 08:45 AM), administration date: 08Jan2022, when the patient was 11 years old, for COVID-19 immunization, reaction(s): "felt light headed", "had pain in her upper back", "Nausea", "severe headache", "fever of 102.5". The following information was reported: INFLUENZA (non-serious) with onset 30Jan2022 17:00, outcome "not recovered", described as "Bad flue symptoms"; PYREXIA (non-serious) with onset 30Jan2022 17:00, outcome "not recovered", described as "Fever of 102.5"; PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (non-serious) with onset 30Jan2022 09:30, outcome "not recovered", described as "patient is 11 years old". The events "bad flue symptoms", "fever of 102.5" and "patient is 11 years old" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of influenza, pyrexia, product administered to patient of inappropriate age.  Additional information: Did the patient receive any other vaccines within 4 weeks prior to the COVID vaccine: no and Prior to vaccination, was the patient diagnosed with COVID-19 was no Since the vaccination, has the patient been tested for COVID-19 was no.   No follow-up attempts are possible. No further information is expected.
GARDASIL 9 was inadvertently given to a 2 month old instead of Prevnar 13, the intended vaccine; No other AEs reported; Information has been received from a vaccine coordinator via a field-based employee referring to a 2 months old patient of unknown gender. The patient's pertinent medical history, drug reactions/allergies, concurrent condition and concomitant medication were not provided.       On an unknown date, the patient was inadvertently vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9)(1 injection; strength, route, anatomical location, lot number and expiration date were not provided) for prophylaxis, instead of pneumococcal vaccine conj 13v (crm197)(PREVNAR 13), the intended vaccine(wrong product administered). No other adverse events(AEs) were reported.
Intense pain in R shoulder, and  R mid back,  unable to breathe , cough, swallow, hiccup or burp without exacerbating the pain, could not lie down, blood in sputum which became heavy by day 3 ER then ICU on day 3      Diagnosis PE           Sputum test in ICU with additional Diagnosis of Mycoplasma Pneumonia Heparin (then apixaban (Eliquis 10 mg BID)) antibiotic
3rd day after shot had lots of phlegm in morning lasting about a week.  Easy to cough up.  Green/yellow.  More than a teaspoon. No breathing problem but did feel fatigued.  After coughing up in morning, no other phlegm all day.  Then, for a week, I had trouble with balancing,  like walking after too many drinks.  That has essentially resolved itself.  OK now.  Really don't know if adverse reaction or possibly a 'bug'.  Thought it best to let you know.
Diarrhea; Had queasiness and nausea; Throwing up; Really bad nausea; Stomach was bothering him; Loose stool several hours later; Felt super tired, on and off sleeping all day; Felt super tired, on and off sleeping all day; Sore arm; This spontaneous case was reported by a nurse and describes the occurrence of PAIN IN EXTREMITY (Sore arm), SOMNOLENCE (Felt super tired, on and off sleeping all day), ABDOMINAL DISCOMFORT (Stomach was bothering him), DIARRHOEA (Loose stool several hours later) and DIARRHOEA (Diarrhea) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 1012A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 on 21-Jan-2021 and Colonoscopy on 24-Jan-2021.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 28-Feb-2021, the patient experienced SOMNOLENCE (Felt super tired, on and off sleeping all day) and FATIGUE (Felt super tired, on and off sleeping all day). On 01-Mar-2021, the patient experienced ABDOMINAL DISCOMFORT (Stomach was bothering him), DIARRHOEA (Loose stool several hours later), NAUSEA (Really bad nausea) and VOMITING (Throwing up). On 10-Mar-2021, the patient experienced DIARRHOEA (Diarrhea) and NAUSEA (Had queasiness and nausea). The patient was treated with ONDANSETRON (ZOFRAN [ONDANSETRON]) for Nausea, at an unspecified dose and frequency. On 02-Mar-2021, DIARRHOEA (Loose stool several hours later), NAUSEA (Really bad nausea) and VOMITING (Throwing up) had resolved. At the time of the report, PAIN IN EXTREMITY (Sore arm), DIARRHOEA (Diarrhea) and FATIGUE (Felt super tired, on and off sleeping all day) outcome was unknown and SOMNOLENCE (Felt super tired, on and off sleeping all day), ABDOMINAL DISCOMFORT (Stomach was bothering him) and NAUSEA (Had queasiness and nausea) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.
had vax on 1MAR93 & temp on 3MAR93 became swollen on 24 days; 3rd day had terrible BM blowout, rash redness under breast, on buttocks & large area of redness @ site; lymph node under lt arm noted; site tender to touch;
Pain in arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in arm) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced PAIN IN EXTREMITY (Pain in arm). On 08-Feb-2021, PAIN IN EXTREMITY (Pain in arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Relevant concomitant medications included medications for blood pressure, HIV medicine, allergy pills, appetite pills and stomach pills. Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-054413 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: form was attached and patient declined further follow up.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-054413:second dose
I tested positive for COVID-19. I had a sore throat; sneezing; and slight fever of 100.5. I called my doctor he prescribed me PAXLOVID. My symptoms lasted for 5 days.
Diarrhea stomach cramps on Sunday afternoon  Very sore arm Saturday to now Feeling like my nose is stuffy or tender but no congestion or mucus